{"id":"amyloid-pet","safety":{"commonSideEffects":[{"rate":null,"effect":"Radiation exposure"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Amyloid PET works by using a radioactive tracer that selectively binds to amyloid beta plaques, allowing for visualization of amyloid deposition in the brain. This can help diagnose and monitor Alzheimer's disease and other amyloid-related conditions.","oneSentence":"Amyloid PET is a diagnostic imaging agent that binds to amyloid beta plaques in the brain.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:01:35.025Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Diagnosis of Alzheimer's disease and other amyloid-related conditions"}]},"trialDetails":[{"nctId":"NCT02669225","phase":"EARLY_PHASE1","title":"Brain Amyloid- Retention During Wakefulness and Following Emergence From Sleep in Healthy People","status":"COMPLETED","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2016-05-02","conditions":"Normal Physiology","enrollment":22},{"nctId":"NCT07099053","phase":"","title":"Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging","status":"RECRUITING","sponsor":"National Institute on Aging (NIA)","startDate":"2026-04-01","conditions":"Aging","enrollment":400},{"nctId":"NCT04847453","phase":"PHASE1","title":"Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-08-03","conditions":"Recurrent AL Amyloidosis, Refractory AL Amyloidosis","enrollment":24},{"nctId":"NCT05617014","phase":"","title":"Alzheimer's Disease Neuroimaging Initiative 4","status":"ENROLLING_BY_INVITATION","sponsor":"University of Southern California","startDate":"2023-06-09","conditions":"Mild Cognitive Impairment, Alzheimer Disease, Dementia","enrollment":1500},{"nctId":"NCT07482072","phase":"","title":"Brain Blood Flow and Sugar Transport in Alzheimer's Disease With and Without Diabetes - A Pilot Imaging Study","status":"RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2026-03","conditions":"Alzheimer Dementia (AD), Diabete Type 2","enrollment":60},{"nctId":"NCT03582488","phase":"PHASE4","title":"Longitudinal Imaging Biomarkers of Disease Progression in DLB","status":"ENROLLING_BY_INVITATION","sponsor":"Kejal Kantarci","startDate":"2018-06-25","conditions":"Lewy Body Disease","enrollment":135},{"nctId":"NCT03019029","phase":"PHASE1, PHASE2","title":"Diagnostic Utility of F-18 Florbetapir PET/MR in Peripheral Nerve Amyloidosis","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2017-03-13","conditions":"Amyloidosis","enrollment":8},{"nctId":"NCT05999084","phase":"","title":"Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-03-06","conditions":"Alzheimer Disease","enrollment":735},{"nctId":"NCT03880240","phase":"PHASE1, PHASE2","title":"Gamma Induction for Alzheimer's Disease","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2019-08-05","conditions":"Alzheimer Disease, Mild Cognitive Impairment","enrollment":17},{"nctId":"NCT02740634","phase":"NA","title":"Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2016-05","conditions":"Atypical Alzheimer's Disease, Logopenic Progressive Aphasia (LPA), Posterior Cortical Atrophy (PCA)","enrollment":60},{"nctId":"NCT07458620","phase":"PHASE1","title":"Prospective Single-Arm Safety Study of Cervical LVA in AD Patients","status":"NOT_YET_RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2026-03","conditions":"Alzheimer's Disease (AD)","enrollment":35},{"nctId":"NCT07284290","phase":"PHASE4","title":"Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia","status":"RECRUITING","sponsor":"Virginia Commonwealth University","startDate":"2025-12-08","conditions":"Dementia With Lewy Bodies, Parkinson Disease Dementia, Healthy Controls","enrollment":120},{"nctId":"NCT07456462","phase":"NA","title":"Making Antibody Treatments More Effective in Early Alzheimer's Disease Using 3Tesla Magnetica Resonance","status":"NOT_YET_RECRUITING","sponsor":"IRCCS San Raffaele","startDate":"2026-05-01","conditions":"Alzheimer Dementia (AD), Mild Cognitive Impairment (MCI)","enrollment":50},{"nctId":"NCT07448623","phase":"PHASE1","title":"A Research Study to Look at the Distribution and Effects of Coramitug on Amyloid Deposits in Heart Tissue Using PET/CT Imaging in People With ATTR Amyloidosis.","status":"NOT_YET_RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2026-03-02","conditions":"Transthyretin Amyloid Cardiomyopathy","enrollment":14},{"nctId":"NCT07431255","phase":"","title":"Generation of Synthetic [18F]FDG PET From Early-Phase Amyloid PET in Alzheimer's Disease","status":"NOT_YET_RECRUITING","sponsor":"IRCCS San Raffaele","startDate":"2026-03-01","conditions":"Alzheimer Disease (AD)","enrollment":35},{"nctId":"NCT03507257","phase":"","title":"Longitudinal Early-onset Alzheimer's Disease Study Protocol","status":"RECRUITING","sponsor":"Indiana University","startDate":"2018-04-30","conditions":"Early Onset Alzheimer Disease, Alzheimer Disease, Mild Cognitive Impairment","enrollment":850},{"nctId":"NCT07417540","phase":"NA","title":"Evaluation of SCALE PET Software for Quantitative Brain PET Analysis in Alzheimer's Disease","status":"COMPLETED","sponsor":"NEUROPHET","startDate":"2025-06-02","conditions":"Alzheimer's Disease (AD), Mild Cognitive Impairment (MCI)","enrollment":190},{"nctId":"NCT06974877","phase":"PHASE1","title":"Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-09-10","conditions":"Cryopyrin-Associated Periodic Syndromes, Amyloidosis","enrollment":30},{"nctId":"NCT06584357","phase":"","title":"Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia","status":"RECRUITING","sponsor":"GAP Innovations, PBC","startDate":"2024-09-26","conditions":"Mild Cognitive Impairment, Alzheimer's Disease, Alzheimer's Disease, Early Onset","enrollment":1200},{"nctId":"NCT06757569","phase":"NA","title":"Radialis PET Imager for the Assessment of Neuritic Amyloid Plaque Burden","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2024-12-06","conditions":"Cognitive Impairment","enrollment":160},{"nctId":"NCT04426539","phase":"","title":"New IDEAS: Imaging Dementia-Evidence for Amyloid Scanning Study","status":"COMPLETED","sponsor":"American College of Radiology","startDate":"2020-12-17","conditions":"Alzheimer's Disease, Dementia, Mild Cognitive Impairment","enrollment":6061},{"nctId":"NCT04818255","phase":"NA","title":"STIM+: PET Biomarker Education & Disclosure","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2020-12-10","conditions":"Mild Cognitive Impairment, Dementia; Alzheimer's Type (Etiology)","enrollment":152},{"nctId":"NCT03860857","phase":"PHASE3","title":"Biomarker Exploration in Aging, Cognition and Neurodegeneration","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2018-05-01","conditions":"Alzheimer Disease, Cognitive Impairment, Cognitive Decline","enrollment":300},{"nctId":"NCT06953167","phase":"","title":"Cognitive Health in Ageing Register: Investigational and Observational Trial Studies in Dementia Research (CHARIOT): Prospective Readiness Cohort (PRO) Longitudinal Study","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2025-03-17","conditions":"Alzheimer's Disease (AD)","enrollment":600},{"nctId":"NCT07347574","phase":"","title":"NeuroCare Community Project: A Community Based Prospective Observational Study for Early Alzheimer's Detection in HK","status":"NOT_YET_RECRUITING","sponsor":"Hong Kong University of Science and Technology","startDate":"2026-02-01","conditions":"AD - Alzheimer's Disease, Mild Cognitive Impairment, Normal Cognition","enrollment":2500},{"nctId":"NCT06547099","phase":"","title":"Study to Understand Novel Biomarkers in Researching Dementia","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2024-08-14","conditions":"Alzheimer Disease, Mild Cognitive Impairment, Dementia","enrollment":1800},{"nctId":"NCT04928534","phase":"","title":"Cohort Study of Blood Biomarkers for TES","status":"COMPLETED","sponsor":"Tianjin Medical University","startDate":"2021-05-01","conditions":"Chronic Traumatic Encephalopathy, Traumatic Encephalopathy, Chronic, Traumatic; Encephalopathy, Postcontusional","enrollment":120},{"nctId":"NCT06257485","phase":"","title":"Bronx Transthyretin Amyloid Cardiomyopathy Database","status":"ACTIVE_NOT_RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2023-09-23","conditions":"Transthyretin Cardiac Amyloidosis, Transthyretin Amyloid Cardiomyopathy","enrollment":476},{"nctId":"NCT05584241","phase":"NA","title":"Behavioral Change Following Alzheimer's Disease (AD) Biomarker Disclosure","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Michigan","startDate":"2023-02-20","conditions":"Mild Cognitive Impairment, Alzheimer Disease, Amnestic Mild Cognitive Disorder","enrollment":100},{"nctId":"NCT06083467","phase":"NA","title":"CW2IP2: Imaging and Diagnostic Assessments","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2023-07-20","conditions":"Tauopathies","enrollment":94},{"nctId":"NCT07309107","phase":"","title":"Deep Learning on Amyloid Positons Emission Tomography","status":"NOT_YET_RECRUITING","sponsor":"Central Hospital, Nancy, France","startDate":"2026-01-06","conditions":"Alzheimer Disease","enrollment":40},{"nctId":"NCT06618872","phase":"NA","title":"Incremental Diagnostic Value of Tau-PET With [18F]RO948 vs Amyloid-PET in Patients With Cognitive Impairment","status":"RECRUITING","sponsor":"University Hospital, Geneva","startDate":"2024-12-03","conditions":"Dementia, Alzheimer Disease","enrollment":120},{"nctId":"NCT06932809","phase":"EARLY_PHASE1","title":"Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2025-05-09","conditions":"Tauopathies","enrollment":90},{"nctId":"NCT05758493","phase":"PHASE2","title":"Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis","status":"RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2023-01-10","conditions":"Amyloidosis, Transthyretin Amyloidosis","enrollment":150},{"nctId":"NCT06788535","phase":"PHASE3","title":"Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sharmila Dorbala","startDate":"2025-01-14","conditions":"Cardiac Amyloidosis","enrollment":200},{"nctId":"NCT03503331","phase":"PHASE2","title":"UAB Alzheimer's Disease Center Core Cohort - Imaging Substudy","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2018-04-20","conditions":"Alzheimer Disease","enrollment":160},{"nctId":"NCT07112066","phase":"NA","title":"Multimodality Cardiac Imaging for Disease Progression in ATTR-CM","status":"RECRUITING","sponsor":"Dominik Benz","startDate":"2025-10-20","conditions":"Amyloidosis Cardiac","enrollment":50},{"nctId":"NCT06023446","phase":"","title":"Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?","status":"ENROLLING_BY_INVITATION","sponsor":"University of California, Davis","startDate":"2023-09-29","conditions":"Alzheimer Disease, Mild Cognitive Impairment","enrollment":100},{"nctId":"NCT06073587","phase":"","title":"The CARDIO-TTRansform Scintigraphy Sub-study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ionis Pharmaceuticals, Inc.","startDate":"2023-04-04","conditions":"Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)","enrollment":150},{"nctId":"NCT06790394","phase":"PHASE1","title":"Test-retest Study With [18F]FBB in Cardiac Amyloidosis","status":"RECRUITING","sponsor":"Life Molecular Imaging GmbH","startDate":"2025-10-21","conditions":"Cardiac Amyloidosis","enrollment":15},{"nctId":"NCT05184088","phase":"PHASE3","title":"Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis","status":"RECRUITING","sponsor":"Life Molecular Imaging GmbH","startDate":"2023-01-13","conditions":"Cardiac Amyloidosis, AL Amyloidosis, ATTR Amyloidosis","enrollment":200},{"nctId":"NCT03821857","phase":"PHASE4","title":"Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2019-06-27","conditions":"Alzheimer Disease","enrollment":614},{"nctId":"NCT04680130","phase":"","title":"Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders","status":"ENROLLING_BY_INVITATION","sponsor":"Mayo Clinic","startDate":"2020-11-01","conditions":"PSP, CBD, PCA","enrollment":500},{"nctId":"NCT01683825","phase":"PHASE4","title":"Imaging Cardiac Amyloidosis: A Pilot Study Using F-18 Florbetapir Positron Emission Tomography","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2013-03-23","conditions":"Cardiac Amyloidosis","enrollment":23},{"nctId":"NCT06032026","phase":"EARLY_PHASE1","title":"Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-HY-2-15","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2023-07-20","conditions":"Tauopathies","enrollment":70},{"nctId":"NCT07232459","phase":"","title":"[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis","status":"RECRUITING","sponsor":"Tianjin Medical University","startDate":"2025-07-21","conditions":"Amyloid, Cardiac Amyloidosis, Amyloidosis","enrollment":25},{"nctId":"NCT06723015","phase":"PHASE2","title":"Tau PET Outcomes With Anti-amyloid Immunotherapies","status":"ENROLLING_BY_INVITATION","sponsor":"Mayo Clinic","startDate":"2025-11-04","conditions":"Cognitive Impairment, Mild, Dementia, Mild, Alzheimer Disease","enrollment":135},{"nctId":"NCT02641145","phase":"NA","title":"Molecular Imaging of Primary Amyloid Cardiomyopathy","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2016-04-01","conditions":"Amyloidosis, Primary, Cardiomyopathy","enrollment":171},{"nctId":"NCT05619302","phase":"PHASE3","title":"Molecular Imaging of Myocardial Fibrosis in Cardiac Amyloidosis","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2023-01-03","conditions":"Cardiac Amyloidosis","enrollment":65},{"nctId":"NCT05361382","phase":"PHASE1","title":"Head-to-Head Harmonization of Tau Tracers in Alzheimer's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tharick Pascoal","startDate":"2022-03-02","conditions":"Alzheimer Disease","enrollment":822},{"nctId":"NCT02951598","phase":"","title":"A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2016-10-29","conditions":"Alzheimer Disease, Mild Cognitive Impairment","enrollment":1400},{"nctId":"NCT01095744","phase":"","title":"Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2009-03","conditions":"Alzheimer's Disease, Posterior Cortical Atrophy, Logopenic Progressive Aphasia","enrollment":60},{"nctId":"NCT05153941","phase":"","title":"Diagnosis and Monitoring of Disease Progression Using Deep Neuro Signatures","status":"ACTIVE_NOT_RECRUITING","sponsor":"Altoida","startDate":"2022-01-31","conditions":"Alzheimer's Disease, Mild Cognitive Impairment","enrollment":3500},{"nctId":"NCT04228666","phase":"PHASE1, PHASE2","title":"A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's Disease","status":"WITHDRAWN","sponsor":"Hope Biosciences LLC","startDate":"2020-03-01","conditions":"Alzheimer Disease","enrollment":""},{"nctId":"NCT03814603","phase":"","title":"The Sleep Amyloid, Slow WAve Race and Ethnicity Study","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2018-11-21","conditions":"Alzheimer Disease","enrollment":210},{"nctId":"NCT06022939","phase":"PHASE3","title":"Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis","status":"RECRUITING","sponsor":"SWOG Cancer Research Network","startDate":"2024-07-01","conditions":"AL Amyloidosis","enrollment":338},{"nctId":"NCT03185208","phase":"PHASE4","title":"Lithium As a Treatment to Prevent Impairment of Cognition in Elders","status":"COMPLETED","sponsor":"Ariel Gildengers, MD","startDate":"2018-02-02","conditions":"Mild Cognitive Impairment","enrollment":83},{"nctId":"NCT07154394","phase":"","title":"Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's Disease","status":"RECRUITING","sponsor":"University Hospital, Essen","startDate":"2022-08-15","conditions":"Dementia, Alzheimer Type, Mild Cognitive Impairment, Cardiac Amyloidosis","enrollment":15},{"nctId":"NCT07154381","phase":"","title":"Hybrid Florbetaben PET/MRI for Imaging of Cardiac Amyloidosis","status":"RECRUITING","sponsor":"University Hospital, Essen","startDate":"2019-12-09","conditions":"Cardiac Amyloidosis","enrollment":25},{"nctId":"NCT05235269","phase":"PHASE2","title":"A Study to Evaluate Organ Level Uptake Repeatability of 124I AT-01 in Subjects With Systemic Amyloidosis","status":"COMPLETED","sponsor":"Attralus, Inc.","startDate":"2021-11-30","conditions":"Amyloidosis","enrollment":33},{"nctId":"NCT07130565","phase":"","title":"Pan-Amyloid PET/CT in Various Amyloid-Related Disease","status":"RECRUITING","sponsor":"Tianjin Medical University","startDate":"2023-11-01","conditions":"Amyloid, Cardiac Amyloidosis, Amyloidosis","enrollment":500},{"nctId":"NCT05453539","phase":"PHASE1","title":"Proof-of-concept Study of New Imaging Diagnostic in Patients With Suspected Alzheimer's Disease","status":"TERMINATED","sponsor":"Alzeca Biosciences, Inc.","startDate":"2022-11-09","conditions":"Alzheimer Disease","enrollment":16},{"nctId":"NCT07103863","phase":"","title":"Multimodal Radiomics Model (18F-FAPI PET/CT + CMR) for AL Cardiac Amyloidosis Prognosis","status":"ENROLLING_BY_INVITATION","sponsor":"Beijing Anzhen Hospital","startDate":"2025-02-13","conditions":"AL Amyloidosis (AL), Cardiac Amyloidosis","enrollment":49},{"nctId":"NCT05374564","phase":"PHASE1","title":"Parametric Cardiac 18F-flutemetamol PET Imaging in ATTR Cardiomyopathy","status":"COMPLETED","sponsor":"Yale University","startDate":"2022-08-16","conditions":"Cardiomyopathies, Primary","enrollment":12},{"nctId":"NCT03706261","phase":"PHASE1","title":"Alzheimer's PET Imaging in Racially/Ethnically Diverse Adults","status":"COMPLETED","sponsor":"Adam Brickman","startDate":"2019-03-22","conditions":"Alzheimer Disease","enrollment":145},{"nctId":"NCT04994847","phase":"","title":"APOE in the Predisposition to, Protection From, and Prevention of Alzheimer's Disease","status":"ENROLLING_BY_INVITATION","sponsor":"Banner Health","startDate":"2021-05-01","conditions":"Alzheimer Disease","enrollment":300},{"nctId":"NCT05635045","phase":"PHASE2","title":"Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR","status":"COMPLETED","sponsor":"Columbia University","startDate":"2022-07-08","conditions":"Transthyretin Amyloidosis","enrollment":10},{"nctId":"NCT00935090","phase":"","title":"3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer","status":"RECRUITING","sponsor":"Barbara Ann Karmanos Cancer Institute","startDate":"2009-09","conditions":"Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders, Leukemia","enrollment":""},{"nctId":"NCT07000851","phase":"","title":"Imaging Studies in Corticobasal Syndrome","status":"RECRUITING","sponsor":"Jennifer Whitwell","startDate":"2025-06-25","conditions":"Cortico Basal Degeneration, Corticobasal Syndrome, Corticobasal Syndrome(CBS)","enrollment":80},{"nctId":"NCT05059158","phase":"","title":"Amyloid-β Clearance Mechanisms in Alzheimer's Disease","status":"RECRUITING","sponsor":"Ludwig-Maximilians - University of Munich","startDate":"2021-06-01","conditions":"Alzheimer's Disease (AD)","enrollment":60},{"nctId":"NCT06224920","phase":"","title":"Activity of Cerebral Networks, Amyloid and Microglia in Aging and Alzheimer's Disease","status":"COMPLETED","sponsor":"Ludwig-Maximilians - University of Munich","startDate":"2017-01-01","conditions":"Alzheimer Disease, Corticobasal Syndrome","enrollment":140},{"nctId":"NCT04576793","phase":"PHASE2","title":"Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease","status":"RECRUITING","sponsor":"Patrick Lao","startDate":"2020-11-17","conditions":"Alzheimer Disease","enrollment":100},{"nctId":"NCT05776212","phase":"","title":"Quantitative-imaging in Cardiac Transthyretin Amyloidosis","status":"RECRUITING","sponsor":"University of Edinburgh","startDate":"2021-08-25","conditions":"ATTR-CM","enrollment":140},{"nctId":"NCT04263337","phase":"PHASE1","title":"NFL LONG Prospective Study","status":"ENROLLING_BY_INVITATION","sponsor":"University of North Carolina, Chapel Hill","startDate":"2020-03-12","conditions":"Concussion, Brain","enrollment":250},{"nctId":"NCT04708613","phase":"","title":"University of Pittsburgh Brain Health Initiative","status":"RECRUITING","sponsor":"David Okonkwo, MD, PhD","startDate":"2019-11-18","conditions":"Traumatic Brain Injury","enrollment":300},{"nctId":"NCT06439992","phase":"","title":"Beta Amyloid PET Imaging for Alzheimer Disease With [18F]-Fluselenamyl","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2023-11-07","conditions":"Alzheimer Disease","enrollment":60},{"nctId":"NCT05731440","phase":"","title":"Fluselenamyl - Beta Amyloid PET Imaging for Alzheimer Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2022-11-18","conditions":"Alzheimer Disease","enrollment":60},{"nctId":"NCT07012993","phase":"PHASE2","title":"Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol","status":"RECRUITING","sponsor":"Akiva Mintz","startDate":"2025-05-20","conditions":"Healthy Volunteer, Alzheimer's Disease, Mild Cognitive Impairment, Other Forms of Dementia","enrollment":200},{"nctId":"NCT06416072","phase":"","title":"Alzheimer's Plasma Extension","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Southern California","startDate":"2023-09-21","conditions":"Preclinical Alzheimer's Disease, Early Preclinical Alzheimer's Disease","enrollment":1000},{"nctId":"NCT00950430","phase":"PHASE4","title":"Imaging of Brain Amyloid Plaques in the Aging Population","status":"ENROLLING_BY_INVITATION","sponsor":"Mayo Clinic","startDate":"2008-04","conditions":"Alzheimer's Disease, Dementia With Lewy Bodies, Frontotemporal Dementia","enrollment":8000},{"nctId":"NCT03560960","phase":"EARLY_PHASE1","title":"Multi-Center Development of a Novel Diagnostic Test for Alzheimer's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston University","startDate":"2020-02-04","conditions":"Alzheimer Disease, Mild Cognitive Impairment","enrollment":57},{"nctId":"NCT06467981","phase":"","title":"Study of the Indications for Amyloid Positon Emission Tomography (PET) Scans and Their Usefulness for Patients With Suspected Alzheimer's Disease (AD)","status":"COMPLETED","sponsor":"Central Hospital, Nancy, France","startDate":"2024-11-01","conditions":"Alzheimer Disease","enrollment":160},{"nctId":"NCT06725706","phase":"","title":"Beta Amyloid PET/CT in Various Aβ-Related Disease","status":"RECRUITING","sponsor":"Tianjin Medical University","startDate":"2012-09-01","conditions":"Amyloid, Beta-Amyloid, Neurodegenerative Diseases","enrollment":500},{"nctId":"NCT02685969","phase":"","title":"Brain Characterization of Amyloid Protein and Glucose Metabolism of ALFA Project Participants","status":"RECRUITING","sponsor":"Barcelonabeta Brain Research Center, Pasqual Maragall Foundation","startDate":"2017-03-01","conditions":"Alzheimer's Disease","enrollment":570},{"nctId":"NCT03278119","phase":"","title":"Sleep Aging and Risk for Alzheimer's 2.0","status":"ACTIVE_NOT_RECRUITING","sponsor":"NYU Langone Health","startDate":"2018-05-01","conditions":"Alzheimer Disease, Sleep Apnea","enrollment":158},{"nctId":"NCT05783934","phase":"NA","title":"Demyelination and Remyelination in Multiple Sclerosis (MS) Detected by Brain Amyloid PET-CT","status":"COMPLETED","sponsor":"Istituti Clinici Scientifici Maugeri SpA","startDate":"2021-07-27","conditions":"Multiple Sclerosis","enrollment":6},{"nctId":"NCT06907849","phase":"PHASE2","title":"124I-Evuzamitide PET/CT Imaging In Patients With Lumbar Spinal Stenosis and Carpal Tunnel Syndrome","status":"ENROLLING_BY_INVITATION","sponsor":"University of Tennessee Graduate School of Medicine","startDate":"2025-05","conditions":"Lumbar Spinal Stenosis, Carpal Tunnel Syndrome (CTS), Cardiac Amyloidosis","enrollment":40},{"nctId":"NCT06600880","phase":"PHASE1","title":"Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau","status":"NOT_YET_RECRUITING","sponsor":"Columbia University","startDate":"2026-08","conditions":"Alzheimer Disease, Early Onset","enrollment":6},{"nctId":"NCT04392960","phase":"NA","title":"Novel Imaging Tools in Newly-diagnosed Patients With Cardiac AL Amyloidosis","status":"RECRUITING","sponsor":"Fondazione IRCCS Policlinico San Matteo di Pavia","startDate":"2020-07-22","conditions":"AL Amyloidosis","enrollment":69},{"nctId":"NCT01606488","phase":"PHASE4","title":"Effects of Brain Beta-Amyloid on Postoperative Cognition","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2012-05","conditions":"Postoperative Cognitive Dysfunction","enrollment":66},{"nctId":"NCT03174938","phase":"NA","title":"The Swedish BioFINDER 2 Study","status":"RECRUITING","sponsor":"Skane University Hospital","startDate":"2017-05-15","conditions":"Dementia, Alzheimer Disease, Parkinson Disease","enrollment":1505},{"nctId":"NCT06121544","phase":"","title":"The Swedish BioFINDER - Preclinical AD Study","status":"RECRUITING","sponsor":"Skane University Hospital","startDate":"2022-04-01","conditions":"Alzheimer Disease, Mild Cognitive Impairment, Mild Dementia","enrollment":800},{"nctId":"NCT04840979","phase":"PHASE2","title":"Discovery and Validation of Genetic Variants Affecting Microglial Activation in Alzheimer's Disease","status":"RECRUITING","sponsor":"Columbia University","startDate":"2021-05-11","conditions":"Alzheimer Disease","enrollment":250},{"nctId":"NCT06303921","phase":"EARLY_PHASE1","title":"Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2024-02-16","conditions":"Tauopathies","enrollment":70},{"nctId":"NCT03744312","phase":"PHASE1, PHASE2","title":"Imaging Inflammation in Alzheimer's Disease With 11C-ER176","status":"COMPLETED","sponsor":"Columbia University","startDate":"2018-09-10","conditions":"Alzheimer Disease","enrollment":9},{"nctId":"NCT03019757","phase":"","title":"Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease","status":"RECRUITING","sponsor":"Douglas Scharre","startDate":"2018-08-30","conditions":"Alzheimer's Disease, Lewy Body Dementia, Parkinson's Disease","enrollment":76},{"nctId":"NCT06889896","phase":"","title":"Clinical Evaluation of Blood-Based Assays for Rapid Detection of Aβ Pathology in Alzheimer's Disease","status":"ENROLLING_BY_INVITATION","sponsor":"Anhui Provincial Hospital","startDate":"2024-07-11","conditions":"Alzheimer's Disease Diagnosis","enrollment":400},{"nctId":"NCT02831283","phase":"PHASE2","title":"Imaging Inflammation in Alzheimer's Disease","status":"COMPLETED","sponsor":"Patrick Lao","startDate":"2016-06","conditions":"Alzheimer's Disease","enrollment":60},{"nctId":"NCT05164536","phase":"PHASE1","title":"Plasma P-tau2017 and Quantitative Amyloid PET Imaging","status":"COMPLETED","sponsor":"Invicro","startDate":"2021-08-27","conditions":"Alzheimer Disease","enrollment":140},{"nctId":"NCT03616496","phase":"NA","title":"Assessment of 18F-Florbetaben Whole-body PET for the Detection of Cardiac and Extracardiac Sites of Amyloid Deposits","status":"COMPLETED","sponsor":"Central Hospital, Nancy, France","startDate":"2019-06-06","conditions":"Cardiac Amyloidosis","enrollment":67}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2069,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"amyloid PET","genericName":"amyloid PET","companyName":"National Taiwan University Hospital","companyId":"national-taiwan-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Amyloid PET is a diagnostic imaging agent that binds to amyloid beta plaques in the brain. Used for Diagnosis of Alzheimer's disease and other amyloid-related conditions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}